{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:03:00Z","timestamp":1781701380389,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jneumeth.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T03:30:40Z","timestamp":1509161440000},"page":"4-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?"],"prefix":"10.1016","volume":"300","author":[{"given":"Anton","family":"Bespalov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Steckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2017.10.018_bib0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/pr.115.010512","article-title":"Dopamine's actions in primate prefrontal cortex: challenges for treating cognitive disorders","volume":"67","author":"Arnsten","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-150029","article-title":"The continuing failure of bexarotene in alzheimer's disease mice","volume":"46","author":"Balducci","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrd.2016.88","article-title":"Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets","volume":"15","author":"Bespalov","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2003.07.002","article-title":"The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys","volume":"46","author":"Buccafusco","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2125.2008.03243.x","article-title":"Hormesis and medicine","volume":"66","author":"Calabrese","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/505612a","article-title":"Policy NIH plans to enhance reproducibility","volume":"505","author":"Collins","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/520271a","article-title":"UK funders demand strong statistics for animal studies","volume":"520","author":"Cressey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0040","doi-asserted-by":"crossref","first-page":"e00010","DOI":"10.1002\/ebm2.10","article-title":"The development of an online database for interventions tested in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Egan","year":"2015","journal-title":"Evid. Based Preclin. Med."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ilar\/ilu047","article-title":"The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it","volume":"55","author":"Garner","year":"2014","journal-title":"ILAR J."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0050","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nn.4365","article-title":"Improving data quality in neuronal population recordings","volume":"26","author":"Harris","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0055","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ygeno.2010.01.003","article-title":"Microarray data quality control improves the detection of differentially expressed genes","volume":"95","author":"Kauffmann","year":"2010","journal-title":"Genomics"},{"issue":"6","key":"10.1016\/j.jneumeth.2017.10.018_bib0060","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature11556","article-title":"A call for transparent reporting to optimize the predictive value of preclinical research","volume":"490","author":"Landis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0070","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1161\/STROKEAHA.108.515957","article-title":"Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality","volume":"39","author":"Macleod","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0075","article-title":"The NPQIP Collaborative group. Findings of a retrospective, controlled cohort study of the impact of a change in Nature journals' editorial policy for life sciences research on the completeness of reporting study design and execution","author":"Macleod","year":"2017","journal-title":"bioRxiv"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0080","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.euroneuro.2015.01.016","article-title":"\u00d6gren SO. Learning from the past and looking to the future: emerging perspectives for improving the treatment of psychiatric disorders","volume":"25","author":"Millan","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.drudis.2011.12.020","article-title":"Can the flow of medicines be improved: fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival","volume":"17","author":"Morgan","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O'Collins","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2015.04.020","article-title":"Lack of support for bexarotene as a treatment for Alzheimer's disease","volume":"100","author":"O'Hare","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/507423a","article-title":"Make mouse studies work","volume":"507","author":"Perrin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/17482960701856300","article-title":"Design, power, and interpretation of studies in the standard murine model of ALS","volume":"9","author":"Scott","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0110","doi-asserted-by":"crossref","first-page":"e1000344","DOI":"10.1371\/journal.pbio.1000344","article-title":"Publication bias in reports of animal stroke studies leads to major overstatement of efficacy","volume":"8","author":"Sena","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0115","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jalz.2016.07.001","article-title":"Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: for funders and researchers","volume":"12","author":"Snyder","year":"2016","journal-title":"Alzheimer\u2019s Dementia"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00213-016-4252-7","article-title":"Reporting guidelines for psychopharmacology","volume":"233","author":"Steckler","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0125","article-title":"Clinical development success rates 2006\u20132015","author":"Thomas","year":"2016","journal-title":"BIO Ind. Anal."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0130","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1523\/JNEUROSCI.5133-12.2013","article-title":"Phosphodiesterase inhibition rescues chronic cognitive deficits induced by traumatic brain injury","volume":"33","author":"Titus","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0135","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1523\/JNEUROSCI.3212-15.2016","article-title":"Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4B inhibitor","volume":"36","author":"Titus","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0140","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/1352458510379612","article-title":"Sena ES, ffrench-Constant C, williams A, chandran S, macleod MR. improving the translational hit of experimental treatments in multiple sclerosis","volume":"16","author":"Vesterinen","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tips.2016.05.003","article-title":"Reproducibility crisis: are we ignoring reaction norms","volume":"37","author":"Voelkl","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0150","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/nm.2965","article-title":"Inhibition of IL-12\/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline","volume":"18","author":"Vom Berg","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1124\/jpet.110.171751","article-title":"Productivity shortfalls in drug discovery: contributions from the preclinical sciences","volume":"336","author":"Williams","year":"2011","journal-title":"J Pharmacol ExpTher"},{"key":"10.1016\/j.jneumeth.2017.10.018_bib0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871527314666150130154757","article-title":"Obstacles to the discovery of medicines for psychiatric disorders in modern times","volume":"14","author":"Witkin","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027017303746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027017303746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:43:58Z","timestamp":1759020238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027017303746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":32,"alternative-id":["S0165027017303746"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2017.10.018","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}